glp-1 gerd drugs increase risk of acid reflux, GERD, study finds Burning chest. Regurgitation. That weird

So well written and the research and insight provided were solid

Indian J Gastroenterol

Tirzepatide works by activating GLP-1 and GIP receptors in your brain, triggering signals that reduce appetite and slow stomach emptying

Theres no credible scientific evidence that these patches lead to meaningful weight loss

Overall, the titration schedules that come with FDA-approved GLP-1 medications were developed through extensive research involving thousands of participants, and they exist for both safety and efficacy reasons

Those who took an oral version of semaglutide did have traces of the medication in their milk supply, which may impact infant development